Ole Dyg Pedersen
机构: Zealand University Hospital, Roskilde
每年引用次数
引用次数
引用: 6,009
H-指数: 24
I10-指数 : 32
出版物: 72
Familial neurofibromatosis and hypertrophic obstructive cardiomyopathy
Pedersen Od , Bagger H
Ugeskrift for Læger 154 ( 1) 26
2
1991
Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Commentary
Marie Seibaek , Niels Falstie-Jensen , Hans Burchardt , Hein J. Wellens
European Heart Journal 27 ( 23)
2006
Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial.
Janus Christian Jakobsen , Michael Hecht Olsen , Christian Gluud , Axel Brandes
BMJ Open 11 ( 3)
2021
Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular Dysfunction
Ole Dyg Pedersen , Henning Bagger , Lars Køber , Christian Torp-Pedersen
Circulation 100 ( 4) 376 -380
988
1999
Influence of plasma platelets on activated protein C resistance assay.
Johannes Sidelmann , Jørgen Gram , Ole Dyg Pedersen , Jørgen Jespersen
Thrombosis and Haemostasis 74 ( 3) 993 -994
22
1995
Deviations in factor XII-dependent plasminogen activator activity in relation to ischaemic heart disease and age
Jørgen Jespersen , Ole Dyg Pedersen , Jørgen Gram , Kristian Korsgaard Thomsen
Fibrinolysis and Proteolysis 6 27 -30
2
1992
Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease.
Jakob Raunsø , Ole Dyg Pedersen , Helena Dominguez , Morten Lock Hansen
European Journal of Heart Failure 12 ( 7) 692 -697
22
2010
Pharmacological stroke prevention: RAS inhibitors
Ole Dyg Pedersen , Christian Torp-Pedersen
Stroke Prevention in Atrial Fibrillation 54 -61
2012
A benefit–risk assessment of class III antiarrhythmic agents
Hanne Elming , Bente Brendorp , Steen Pehrson , Ole Dyg Pedersen
Expert Opinion on Drug Safety 3 ( 6) 559 -577
18
2004
Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
Ole Dyg Pedersen , Bente Brendorp , Hanne Elming , Steen Pehrson
Cardiac Electrophysiology Review 7 ( 3) 220 -224
35
2003
Prevalence, Prognostic Significance, and Treatment of Atrial Fibrillation in Congestive Heart Failure With Particular Reference to the DIAMOND-CHF Study
Ole Dyg Pedersen , Bente Brendorp , Lars Køber , Christian Torp-Pedersen
Congestive Heart Failure 9 ( 6) 333 -340
14
2003
Rhythm control versus rate control for atrial fibrillation and heart failure
Denis Roy , Mario Talajic , Stanley Nattel , D George Wyse
The New England Journal of Medicine 358 ( 25) 2667 -2677
1,138
2008
Can antiarrhythmic drugs save lives in patients with congestive heart failure
Bente Brendorp , Ole Dyg Pedersen , Hanne Elming , Lars Køber
Expert Review of Cardiovascular Therapy 1 ( 2) 191 -202
2003
Diagnostic value of exercise-induced changes in circulating high sensitive troponin T in stable chest pain patients.
Mette Rauhe Mouridsen , Olav Wendelboe Nielsen , Ole Dyg Pedersen , Christian Malchau Carlsen
Biomarkers 18 ( 8) 726 -733
3
2013
Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizations.
Charlotte Andersson , Maria Lukács Krogager , Regitze Kuhr Skals , Emil Vincent Rosenbaum Appel
PLOS ONE 14 ( 2)
1
2019
Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction
Ole Dyg Pedersen , Henning Bagger , Lars Køber , Christian Torp-Pedersen
International Journal of Cardiology 100 ( 1) 65 -71
29
2005
Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
Ole Dyg Pedersen , Jørgen Gram , Jørgen Jespersen
Thrombosis and Haemostasis 73 ( 5) 835 -840
25
1995
The immediate future for the medical treatment of atrial fibrillation
Ole Dyg Pedersen , Bente Brendorp , Lars Køber , Christian Torp-Pedersen
Expert Opinion on Emerging Drugs 7 ( 2) 259 -268
1
2002
New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Redi Pecini , Hanne Elming , Ole Dyg Pedersen , Christian Torp-Pedersen
Expert Opinion on Emerging Drugs 10 ( 2) 311 -322
14
2005
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
Ole Dyg Pedersen , Jørgen Gram , Henning Bagger , Niels Kellert
Coronary Artery Disease 5 ( 7) 617 -624
16
1994